Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes ; volume:21 ; number:1 ; day:17 ; month:2 ; year:2024 ; pages:1-15 ; date:12.2024
Journal of neuroinflammation ; 21, Heft 1 (17.2.2024), 1-15, 12.2024
- Urheber
-
Kodosaki, Eleftheria
Watkins, W. John
Loveless, Sam
Kreft, Karim L.
Richards, Aidan
Anderson, Valerie
Hurler, Lisa
Robertson, Neil P.
Zelek, Wioleta M.
Tallantyre, Emma C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-024-03036-4
- URN
-
urn:nbn:de:101:1-2404250828550.456826777961
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kodosaki, Eleftheria
- Watkins, W. John
- Loveless, Sam
- Kreft, Karim L.
- Richards, Aidan
- Anderson, Valerie
- Hurler, Lisa
- Robertson, Neil P.
- Zelek, Wioleta M.
- Tallantyre, Emma C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis
T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression
Molecular biomarkers in multiple sclerosis
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
Fluid biomarkers for amyotrophic lateral sclerosis: a review
Digital biomarkers for immunotherapy in multiple sclerosis patients
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Improving the diagnosis of common parotid tumors via the combination of CT image biomarkers and clinical parameters
Two independent epigenetic biomarkers predict survival in neuroblastoma
Combination of laser microdissection, 2D-DIGE and MALDI-TOF MS to identify protein biomarkers to predict colorectal cancer spread
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis
T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression
Molecular biomarkers in multiple sclerosis
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
Fluid biomarkers for amyotrophic lateral sclerosis: a review
Digital biomarkers for immunotherapy in multiple sclerosis patients
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Improving the diagnosis of common parotid tumors via the combination of CT image biomarkers and clinical parameters
Two independent epigenetic biomarkers predict survival in neuroblastoma
Combination of laser microdissection, 2D-DIGE and MALDI-TOF MS to identify protein biomarkers to predict colorectal cancer spread
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis
T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression
Molecular biomarkers in multiple sclerosis
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
Fluid biomarkers for amyotrophic lateral sclerosis: a review
Digital biomarkers for immunotherapy in multiple sclerosis patients
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Improving the diagnosis of common parotid tumors via the combination of CT image biomarkers and clinical parameters
Two independent epigenetic biomarkers predict survival in neuroblastoma
Combination of laser microdissection, 2D-DIGE and MALDI-TOF MS to identify protein biomarkers to predict colorectal cancer spread